Triamcinolone

CAS No. 124-94-7

Triamcinolone ( Triamcinolone; Triamcet; Triamcinolon; Triamcinolona; )

Catalog No. M11007 CAS No. 124-94-7

Triamcinolone is a long-acting synthetic corticosteroid.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Triamcinolone
  • Note
    Research use only, not for human use.
  • Brief Description
    Triamcinolone is a long-acting synthetic corticosteroid.
  • Description
    Triamcinolone is a long-acting synthetic corticosteroid.
  • Synonyms
    Triamcinolone; Triamcet; Triamcinolon; Triamcinolona;
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX; Glucocorticoid Receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    124-94-7
  • Formula Weight
    394.44
  • Molecular Formula
    C21H27FO6
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 1 mg/mL (2.53 mM); DMSO: 79 mg/mL (200.28 mM)
  • SMILES
    C[C@@]12[C@](C(CO)=O)(O)[C@H](O)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O
  • Chemical Name
    Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Schaefer EC, et al. Am J Vet Res. 2009 Dec;70(12):1494-50
molnova catalog
related products
  • SC 58125

    SC-58125 is a selective cyclooxygenase 2 (COX-2) inhibitor,?with an IC50 of 0.04 μM. SC-58125 exhibits antitumor activity in vitro and in vivo, and it also can inhibit edema at the inflammatory site and is analgesicSC-58125 treatment on the growth of human colon carcinoma cells in nude mice.?

  • Phenetidine

    Used in the manufacture of acetophenetidin.

  • sphondin

    Sphondin has anticonvulsant anti-inflammatory and anti-proliferative activities it possessed an inhibitory effect on IL-1beta-induced increase in the level of COX-2 protein and PGE(2) release in A549 cells.